Dual antiplatelet therapy duration after drug-eluting stents: how long?
- PMID: 27620368
- PMCID: PMC4999771
- DOI: 10.21037/jtd.2016.07.45
Dual antiplatelet therapy duration after drug-eluting stents: how long?
Conflict of interest statement
Conflicts of Interest: Grants from Fédération française de cardiologie, Cordis,Boston, Medtronic, Terumo, Biotronik; personal fees from Astra Zeneca, Abbott, Pfizer, Boehringer-Ingelheim, Bayer.
Comment on
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2016 Sep 6;68(10):1116-39. doi: 10.1016/j.jacc.2016.03.512. Epub 2016 Mar 29. J Am Coll Cardiol. 2016. PMID: 27036919
References
-
- Authors/Task Force members , Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541-619. 10.1093/eurheartj/ehu278 - DOI - PubMed
-
- Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651. 10.1161/CIR.0b013e31823ba622 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources